02380 408 600 Contact us Book a course

Home
Conducting Studies
Consulting
Institute of Pharmacovigilance Sciences
Education & Training
Who we are
Information & News

Menu

×

Home
Conducting Studies
Consulting
Institute of Pharmacovigilance Sciences
Education & Training
Who we are
Information & News

Reasons for and time to discontinuation of rimonabant therapy: a Modified Prescription-Event Monitoring Study

Post navigation

Previous: Indicators of drug-seeking aberrant behaviours: The feasibility of use in observational post-marketing cohort studies for risk management.

Next: Incidence of venous thromboembolism in users of strontium ranelate: an analysis of data from a prescription-event monitoring study in England

Interested in conducting a study?

Get in touch today to discuss your requirements

Services

Conducting Studies
Consulting
Institute of Pharmacovigilance Sciences
Education & Training

Information

Publications
DSRU News
Press
General Practitioners
Conference Abstracts

Organisation

About Us
Meet The Team
Job Vacancies
Privacy Policy
Terms & Conditions

© 2023 DSRU - Bursledon Hall, Blundell Lane, Southampton, SO31 1AA | Registered Charity No. 327206 | Designed & developed by Dolia